middle.news
ResMed Posts 9% Revenue Growth Amid Patent Battles and $150M Buyback
8:26am on Monday 3rd of November, 2025 AEDT
•
Healthcare
Read Story
ResMed Posts 9% Revenue Growth Amid Patent Battles and $150M Buyback
8:26am on Monday 3rd of November, 2025 AEDT
Key Points
9% year-over-year net revenue growth to $1.34 billion
12% increase in net income to $348.5 million
Gross margin improved to 61.5% due to operational efficiencies
Recorded $15.8 million restructuring expenses related to workforce planning
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE